Evidence mapPaperPMID 40572707Full record

ArticleMedicina (Kaunas, Lithuania)2025

Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study.

Mehmet Ali Ucar, Anıl Tombak, Aydın Akdeniz, Hüseyin Derya Dinçyürek, Meryem Şener, Mahmut Bakır Koyuncu, Eyüp Naci Tiftik, Recep Dokuyucu

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mehmet Ali UcarDepartment of Hematology, Faculty of Medicine, Balcalı Hospital, Cukurova University, Adana 01330, Turkey.
Anıl TombakDepartment of Internal Medicine, Division of Hematology, Faculty of Medicine, Mersin University, Mersin 33110, Turkey.
Aydın AkdenizDepartment of Internal Medicine, Division of Hematology, Faculty of Medicine, Mersin University, Mersin 33110, Turkey.
Hüseyin Derya DinçyürekDepartment of Hematology, Faculty of Medicine, Balcalı Hospital, Cukurova University, Adana 01330, Turkey.
Meryem ŞenerDepartment of Hematology, Faculty of Medicine, Balcalı Hospital, Cukurova University, Adana 01330, Turkey.
Mahmut Bakır KoyuncuDepartment of Internal Medicine, Division of Hematology, Faculty of Medicine, Mersin University, Mersin 33110, Turkey.
Eyüp Naci TiftikDepartment of Internal Medicine, Division of Hematology, Faculty of Medicine, Mersin University, Mersin 33110, Turkey.
Recep DokuyucuDepartment of Physiology, Medical Specialty Training Center (TUSMER), Ankara 06420, Turkey.ORCID 0000-0001-6837-3477

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersHematologic NeoplasmsInflammationAdultAgedCohort StudiesFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisProportional Hazards ModelsRetrospective StudiesSurvival AnalysisBiomarkershematologic malignanciesinflammatory markersoverall survivalpan-immune-inflammation value (PIV)prognosissystemic immune-inflammation index (SII)

Identifiers

PMID40572707
PMCPMC12194995

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.